1. Basic Information

Name:ARAF_HUMAN
Accession#:P10398
Description:Serine/threonine-protein kinase A-raf
AA Number:606
Sequence:
1
51
101
151
201
251
301
351
401
451
501
551
601
   MEPPRGPPAN GAEPSRAVGT VKVYLPNKQR TVVTVRDGMS VYDSLDKALK
VRGLNQDCCV VYRLIKGRKT VTAWDTAIAP LDGEELIVEV LEDVPLTMHN
FVRKTFFSLA FCDFCLKFLF HGFRCQTCGY KFHQHCSSKV PTVCVDMSTN
RQQFYHSVQD LSGGSRQHEA PSNRPLNELL TPQGPSPRTQ HCDPEHFPFP
APANAPLQRI RSTSTPNVHM VSTTAPMDSN LIQLTGQSFS TDAAGSRGGS
DGTPRGSPSP ASVSSGRKSP HSKSPAEQRE RKSLADDKKK VKNLGYRDSG
YYWEVPPSEV QLLKRIGTGS FGTVFRGRWH GDVAVKVLKV SQPTAEQAQA
FK
NEMQVLRK TRHVNILLFM GFMTRPGFAI ITQWCEGSSL YHHLHVADTR
FDMVQLIDVA RQTAQGMDYL HAKNIIHRDL KSNNIFLHEG LTVKIGDFGL
ATVK
TRWSGA QPLEQPSGSV LWMAAEVIRM QDPNPYSFQS DVYAYGVVLY
ELMTGSLPYS HIGCRDQIIF MVGRGYLSPD LSKISSNCPK AMRRLLSDCL
KFQREERPLF PQILATIELL QRSLPKIERS ASEPSLHRTQ ADELPACLLS
AARLVP
*Highlighted peptides (with yellow background) have developed assays.
*Green background amino acids are PTMs.

2. Protein Separation

Sample Preparation: Cells from Melanoma cancer lines were lysed in 8M urea/ 100mM ammonium bicarbonate buffer on ice. The equivalent of 200,000 cells were loaded onto a SDS gel. The protein of interest was excised and ingel digestion with trypsin was performed after reduction and alkylation with TCEP and IAA. 1/6 of the resulting digest was then analyzed on a Thermo Scientific TSQ mass spectrometer.

 

3. LC-MS/MS Data

FLFHGFR

    No LC-MS/MS for this peptide.

GYLSPDLSK

    No LC-MS/MS for this peptide.

SASEPSLHR

    No LC-MS/MS for this peptide.

GSPSPASVSSGR

    No LC-MS/MS for this peptide.

DQIIFMVGR

    No LC-MS/MS for this peptide.

DGMSVYDSLDK

    No LC-MS/MS for this peptide.

IGTGSFGTVFR

    No LC-MS/MS for this peptide.

IGDFGLATVK

    No LC-MS/MS for this peptide.

QQFYHSVQDLSGGSR

    No LC-MS/MS for this peptide.

EERPLFPQILATIELLQR

    No LC-MS/MS for this peptide.

VSQPTAEQAQAFK

    No LC-MS/MS for this peptide.

4. LC-MRM Screening

Peptides screening: Peptides and transitions for analysis were selected using a predictive peptide program. The results were screened for those with the highest specificity and the most intense transitions.